Response to Letter Regarding Article, “Efficacy and Safety of Omalizumab Combined With Allergen Immunotherapy in Children With Moderate to Severe Allergic Asthma”

Documenti analoghi

• Efficacy and Safety of Omalizumab Combined With Allergen Immunotherapy in Children With Moderate to Severe Allergic Asthma: Limitations and Future Directions
  di: Yitong Weng, et al.
  Pubblicazione: (2025)
• Efficacy and Safety of Combined Pharmacotherapies in Moderate‐to‐Severe Allergic Rhinitis: A Network Meta‐Analysis
  di: Yuan Zhang, et al.
  Pubblicazione: (2025)
• Inflammatory Mediator Profiles in the Unchallenged Sinonasal Mucus of Allergic Rhinitis Patients Set to Begin Allergen Immunotherapy
  di: Cameron P. Worden, et al.
  Pubblicazione: (2025)
• Letter to the Editor Regarding “Efficacy of Using Photobiomodulation Therapy in Allergic Rhinitis: A Placebo‐Controlled Randomized Clinical Trial”
  di: Sanjeev Yadav, et al.
  Pubblicazione: (2025)
• Letter to the Editor Regarding “Do Skin Prick Tests Predict Nasal Provocation Test Outcomes in Allergic Rhinitis Patients?”
  di: Xu Li, et al.
  Pubblicazione: (2025)